Pfizer mRNA Flu Vaccine

A Phase III, multicenter, clinical trial to evaluate the efficacy, safety, tolerability, and immunogenicity of the Pfizer quadrivalent modified RNA (modRNA) influenza vaccine candidate

• Read More at Pfizer
• Read More at fluvaccinestudy.com